Dihydromagnolol – a Potent Anxiolytic-like Agent in Mice

References

• Commissaris RL (1993): Conflict behaviors as animal models for study of anxiety. In: Haaren FV, ed., Methods in Behav-ioral Pharmacology. Amsterdam, Elsevier, pp. 443-474.
   Google Scholar
• Fujita M, Itokawa H, Sashida Y (1973): Studies on the compo-nents of Magnolia obovata Thunb. III. Occurrence of mag-nolol and honokiol in M. obovata and other allied plants. Yakugaku Zasshi 93: 429–434.
   Google Scholar
• Hattori M, Endo Y, Takabe S, Kobashi K, Fukasaku N, Namba T (1986): Metabolism of magnolol from Magnoliae cortex. II. Absorption, metabolism and excretion of [ring-14C] magnolol in rats. Chem Pharm Bull 34: 157–167.
   Google Scholar
• Hattori M, Sakamoto T, Endo Y, Kakiuchi N, Kobashi K, Mizuno T, Namba T (1984): Metabolism of magnolol from Magnoliae cortex. I. Application of liquid chromatography-
   Google Scholar
• mass spectrometry to the analysis of metabolites of mag-nolol in rats. Chem Pharm Bull 32: 5010-5017.
   Google Scholar
• Ito Y, Koshiba T, Doi M, Asami S, Fukuda H, Murakoshi Y (1992): Characterization of antagonistic activity and binding properties of SR 95531, a pyridazinyl-GABA derivative, in rat brain and cultured cerebellar neuronal cells. Synapse 10: 326–333.
   PubMedGoogle Scholar
• Ito Y, Miyasaka T, Fukuda H, Akahane K, Kimura Y (1996): Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds. Neuropharmacology 35: 1263–1269.
   PubMedGoogle Scholar
• Ito Y, Segawa K, Fukuda H (1995): Functional diversity of GABAA receptor ligand-gated chloride channels in rat synaptoneurosomes. Synapse 19: 188–196.
   PubMedGoogle Scholar
• Kuribara H, Haraguchi H, Tadokoro S (1989): An anticonflict effect of caffeine: investigation by punished and hypertonic NaC1 solution procedure in mice. Jpn J Alcohol Drug Depend 24: 144–153.
   PubMedGoogle Scholar
• Kuribara H, Kishi E, Kimura M, Weintraub ST, Maruyama Y (2000a): Comparative assessment of the anxiolytic-like activities of honokiol and derivatives. Pharmacol Biochem Behav 67: 597–601.
   PubMed Web of Science ®Google Scholar
• Kuribara H, Kishi E, Maruyama Y (2000b): Does dihydro-honokiol, a potent anxiolytic compound, develop benzodi-azepine-like side effects? J Pharm Pharmacol 52: 1017–1022.
   Google Scholar
• Kuribara H, Maruyama Y (1996): The anxiolytic effect of ori-ental herbal medicines by an improved plus-maze test in mice: Involvement of benzodiazepine receptors. Jpn J Neuropsychopharmacol 18: 179–190.
   Web of Science ®Google Scholar
• Kuribara H, Morita M, Ishige A, Hayashi K, Maruyama Y (1996): Investigation of the anxiolytic effect of the extracts derived from Saiboku-to, an oriental herbal medicine, by an improved plus-maze test in mice. Jpn J Neuropsychophar-macol 18: 643–653.
   Google Scholar
• Lister RG (1987): The use of a plus-maze to measure anxiety in the mouse. Psychopharmacol 92: 180–185.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
   PubMed Web of Science ®Google Scholar
• Maruyama Y, Kuribara H, Kishi E, Weintraub ST, Ito Y (2001): Confirmation of the anxiolytic-like effect of dihydro- honokiol following behavioural and biochemical assess-ments. J Pharm Pharmacol 53: 721–725.
   PubMedGoogle Scholar
• Maruyama Y, Kuribara H, Morita M, Yuzurihara M, Weintraub ST (1998): Identification of magnolol and honokiol as anx-iolytic agents in extracts of Saiboku-to, an oriental herbal medicine. J Nat Prod 61: 135–138.
   PubMed Web of Science ®Google Scholar
• Miller LG, Greenblatt DJ, Roy RB, Summer WR, Shader RI (1988a): Chronic benzodiazepine administration. II. Dis-continuation syndrome is associated with up regulation of y-aminobutyric acid A receptor binding and function. J Pharmacol Exp Ther 246: 177–182.
   Google Scholar
• Miller LG, Weill CL, Roy RB, Gayer A (1988b): Lorazepam administration during embryonic development alters GABAA receptor binding and function. Dev Brain Res 44: 241–246.
   PubMedGoogle Scholar
• Olsen RW, Tobin AJ (1990): Molecular biology of GABAA receptors. FASEB J 4: 2240–2253.
   Google Scholar
• Schwartz RD, Suzudak PD, Paul SM (1986): y-Aminobutyric acid (GABA)- and barbiturate-mediated 36c1 uptake in rat brain synaptoneurosomes: Evidence for rapid desensitiza-tion of the GABA receptor-coupled chloride ion channel. Molec Pharmacol 30: 419–426.
   PubMed Web of Science ®Google Scholar
• Sieghart W (1992): GABAA receptors: Ligand-gated Cl- ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 12: 446–450.
   Google Scholar
• Umezu T (1999): Effects of psychoactive drugs in the Vogel con-flict test in mice. Jpn J Pharmacol 80: 111–118.
   PubMedGoogle Scholar
• Vogel JR, Beer B, Clody DE (1971): A simple and reliable con-flict procedure for testing antianxiety agents. Psychophar-macologia 21: 1–7.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Watanabe K, Hagino K (1983a): Chemostructural requirement for centrally acting muscle relaxant effect of magnolol and honokiol, neolignane derivatives. J Pharma-cobiodyn 6: 184–190.
   PubMedGoogle Scholar
• Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K (1983b): Pharmaclological properties of mag-nolol and honokiol extracted from Magnolia officinalis: Central depressant effects. Planta Med 49: 103–108.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Watanabe H, Goto Y, Yamamoto N, Yoshizaki M (1975): Studies on the active principles of magnolia bark. Centrally acting muscle relaxant activity of magnolol and honokiol. Japan J Phamacol 25: 605–607.
   Google Scholar